Anaxiom
Laguna Hills, US · Founded 2013 · Delaware corporation
Anaxiom develops a minimally invasive implantable device to treat obesity by modulating blood flow, offering an alternative to surgery and medication for patients and physicians seeking weight loss solutions.
Founders & leadership
AW
Andrew WadeExecutive
HB
Hakon BergheiminPresident & CEO
SR
Sharon RiddleinVice President, Market & Clinical Development
HN
HUGH NEUHARTHNamed on SEC filing
CM
Chris MassengalePrincipal R&D Engineer
Board
OB
OLAV B. BERGHEIMBoard director
SM
SHAHRAM MOADDEBBoard director
Reported raises · per SEC filings
Form D private placements$9.5M disclosed across 4 rounds · 2016–2025
▶$5.4MraisedApr 2025 · 9 investors · Other Health CareRule 506(b)
▶$5.4MraisedApr 2025 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew WadeExecutive Officer
- HAKON BERGHEIMDirector
- SHAHRAM MOADDEBDirector
- OLAV B. BERGHEIMExecutive Officer, Director
- Offering amount
- $7.7M
- Amount sold
- $5.4M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$696.1KraisedFeb 2023 · 5 investors · Other Health CareRule 506(b)
▶$696.1KraisedFeb 2023 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew WadeExecutive Officer
- OLAV B. BERGHEIMExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $696.1K
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJan 2018 · 4 investors · Other Health CareRule 506(b)
▶$2.5MraisedJan 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- HUGH NEUHARTHExecutive Officer, Promoter
- OLAV B. BERGHEIMExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$900KraisedMar 2016 · 2 investors · Other Health CareRule 506(b)
▶$900KraisedMar 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- HUGH NEUHARTHExecutive Officer, Promoter
- OLAV B. BERGHEIMExecutive Officer, Director, Promoter
- Offering amount
- $900K
- Amount sold
- $900K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Practo6 shared keywordsPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Procyrion4 shared keywordsProcyrion develops medical devices for circulatory support in heart failure treatment, supported by a team of cardiologists and medical device industry veterans.
Kelsey-Seybold Clinic4 shared keywordsKelsey-Seybold Clinic is a multispecialty healthcare provider offering primary care, pediatric, and specialty medical services across more than 40 locations, with online appointment booking and virtual urgent care. It serves patients in the Houston, Texas area and accepts Medicare Advantage plans.
Companies competing with Anaxiom for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Anaxiom do?
- Anaxiom develops a minimally invasive implantable device to treat obesity by modulating blood flow, offering an alternative to surgery and medication for patients and physicians seeking weight loss solutions.
- How much funding has Anaxiom raised?
- Anaxiom has disclosed $9.5M raised across 4 rounds.
- Where is Anaxiom headquartered?
- Anaxiom is headquartered in Laguna Hills, US.